Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis: Results of a randomized double-blind study

Piet Geusens(KU Leuven), Paul Richardson(University of Liverpool), J Rovenský, Gerhard Krammer, Georg Kralidis, Daniel B. Sloan(University of Virginia), R. Alten

Document Server@UHasselt (UHasselt)

January 1, 2003

Cited by 3

Related Papers

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

|Journal of Hepatology|2000|205

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

|The Lancet HIV|2020|177

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

|The Lancet Diabetes & Endocrinology|2019|171

EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures

|Annals of the Rheumatic Diseases|2016|155

Severe hepatitis E infection during pregnancy

|Journal of Viral Hepatitis|1997|144